Skip to content

This content is in French.

Tofacitinib in vitiligo

2 avril 2024

Tofacitinib in vitiligo

Vitiligo is a skin depigmentation disease resulting from the destruction of melanocytes, often concomitant with autoimmune diseases such as hyperthyroidism or systemic lupus erythematosus. The efficacy of available…

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Qingxia Lin et al. A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib. Clin Cosmet Investig Dermatol. 2024 Mar 20:17:707-711

View the source